HR 2747 · 107th Congress 2001โ€“2003, ended

Stem Cell Research for Patient Benefit Act of 2001

Latest action · Aug 10, 2001 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedAug 2, 2001
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Stem Cell Research for Patient Benefit Act 2001 - Requires the Director of the National Institutes of Health to: (1) conduct or support research using human pluripotent stem cells from embryos and fetal tissue in accordance with the National Institutes of Health Guidelines for Research Using Human Pluripotent Stem Cells; and (2) study and report to specified congressional committees on stem cells and the effectiveness of such guidelines.

Requires the Secretary of Health and Human Services to enter into an agreement with: (1) the Institute of Medicine under which the Institute shall assess the current state of knowledge about therapies, including somatic cell nuclear transfer and therapies using pharmaceuticals, that may be used to address immunological rejection of stem cells and differentiated cells and tissue derived from stem cells; and (2) another appropriate public or nonprofit private entity to conduct such assessment if the Institute declines.

Establishes the Biomedical Advisory Commission to study: (1) bioethical issues arising from research on human biology and applications of such research; and (2) emerging biomedical research, including the ethical, social, legal, and regulatory issues concerning such research and its clinical applications.

Cosponsors 15

Members who signed on, in the order they did. Signatures ran from Aug 2, 2001 to Oct 12, 2001; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-MNJim RamstadOriginalAug 2, 2001
D-CABob FilnerSep 6, 2001
R-WAGeorge R. Nethercutt Jr.Sep 6, 2001
D-WIGerald D. KleczkaSep 6, 2001
R-PAJames C. GreenwoodSep 6, 2001
D-MAJames P. McGovernSep 6, 2001
D-RIJames R. LangevinSep 6, 2001
D-FLKaren L. ThurmanSep 6, 2001
D-ILLane EvansSep 6, 2001
D-TXMax SandlinSep 6, 2001
D-VARick BoucherSep 6, 2001
D-PARobert A. BradySep 6, 2001
D-MABarney FrankOct 12, 2001
D-MILynn N. RiversOct 12, 2001
D-METhomas H. AllenOct 12, 2001

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Aug 2, 2001
Health Subcommittee
Referred Aug 10, 2001

Actions 3

Everything that happened, newest first.

  1. Aug 10, 2001Referred to the Subcommittee on Health.
  2. Aug 2, 2001Introduced in House
  3. Aug 2, 2001Referred to the House Committee on Energy and Commerce.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To require implementation of the National Institutes of Health Guidelines for Research Using Human Pluripotent Stem Cells, and for other purposes.
Short Titles as Introduced
Stem Cell Research for Patient Benefit Act of 2001

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Aug 2, 2001Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.